NASDAQ · Biotechnology

Kodiak Sciences Inc (KOD) Stock

$94.26 +3.49% NASDAQ: KOD Healthcare

Valuation

MetricValue
Price$94.26
Market Cap$5.90B
P/E Ratio-22.54
P/B Ratio96.82
P/S Ratio0.00
EPS (TTM)$-4.32
52-Week High$104.00
52-Week Low$10.94
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-273.23%
ROA-94.23%
ROCE-120.77%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity1.57
Current Ratio4.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-267.0M$-341.0M$-277.0M$-187.0M$-234.0M
Net Profit$-267.0M$-334.0M$-260.0M$-176.0M$-230.0M
EPS$-5.16$-6.39$-4.97$-3.35$-4.32
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$904.0M$667.0M$479.0M$336.0M$352.0M
Total Liabilities$241.0M$230.0M$214.0M$185.0M$194.0M
Cash$732.0M$190.0M$286.0M$168.0M$210.0M
Borrowings$180.0M$188.0M$182.0M$70.0M$159.0M

Latest News

Kodiak CFO Sells $1 Million in Stock as Shares Surge 650%. What Investors Should Know Motley Fool · Jun 10, 2026 Kodiak Sciences (KOD) Is Down 15.4% After Strong Zenkuda GLOW2 Data And Accelerated Filing Plans Simply Wall St. · Jun 6, 2026 Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know Zacks · Jun 4, 2026 Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference PR Newswire · May 28, 2026 Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase Motley Fool · May 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-182.0M$-206.0M$-154.0M$-117.0M$-136.0M
Investing Cash Flow$-102.0M$-384.0M$208.0M$-1.0M$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-213.0M$-541.0M$95.0M$-118.0M$42.0M
Free Cash Flow$-246.0M$-254.0M$-196.0M$-118.0M$-137.0M

Valuation & Return Ratios

MetricValue
PEG Ratio2.19
EV / EBITDA-26.72
FCF Yield-2.71%
Quick Ratio2.49
Interest Coverage0.00
Return 1Y651.25%
Return 3Y475.03%
Return 5Y-51.13%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BLCOBausch + Lomb Corporation $17.15 -1.10% -35.85 $6.13B 0.00%
BLTEBelite Bio, Inc $157.14 -2.45% -61.62 $6.30B 0.00%
EYPTEyePoint, Inc. $3.48 +0.58% -0.91 $291.77M 0.00%
FDMT4D Molecular Therapeutics, Inc. $12.70 +0.87% -5.03 $663.91M 0.00%
KPRXKiora Pharmaceuticals, Inc. $2.53 +0.00% -1.02 $11.21M 0.00%

About Kodiak Sciences Inc

Kodiak Sciences Inc (KOD) stock trades at $94.26 with a market capitalization of $5.90B. The stock is valued at a price-to-earnings (P/E) ratio of -22.54, price-to-book of 96.82, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $10.94 and $104.00, and currently trades 9.4% below its 52-week high.

On profitability, Kodiak Sciences Inc generates a return on equity (ROE) of -273.23%, return on capital employed of -120.77%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1171.57 +0.17% JNJ Johnson & Johnson $259.05 +1.00% ABBV AbbVie Inc. $275.98 +1.30% MRK Merck & Company, Inc. Common Stock (new) $144.50 +1.49% UNH UnitedHealth Group Incorporated Common Stock (DE) $374.02 +0.83% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $651.63 -0.05% AMGN Amgen Inc. $412.50 +1.24% GILD Gilead Sciences, Inc. $149.51 +1.64% ABT Abbott Laboratories $99.93 +1.46% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides